×
Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy

Aerovate Therapeutics Income Statement 2019-2025 | AVTE

Annual Data | Millions of US $ except per share data
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Revenue
-
-
-
-
-
Cost Of Goods Sold
-
-
-
-
-
Gross Profit
-
-
-
-
-
$64.219
$38.622
$14.987
$7.94
$3.112
$17.19
$14.615
$8.035
$0.949
$0.218
Other Operating Income Or Expenses
-
-
-
-
-
Operating Expenses
-
-
-
-
-
$-81.409
$-53.237
$-23.022
$-8.889
$-3.33
Total Non-Operating Income/Expense
$5.944
$1.751
$0.062
$-0.722
$0.001
$-75.465
$-51.486
$-22.96
$-9.611
$-3.329
Income Taxes
$0.056
$0.025
$0.003
-
$0.001
$-75.521
$-51.511
$-22.963
$-9.611
$-3.33
Other Income
-
-
-
-
-
$-75.521
$-51.511
$-22.963
$-9.611
$-3.33
Income From Discontinued Operations
-
-
-
-
-
$-75.521
$-51.511
$-22.963
$-9.611
$-3.33
EBITDA
$-84.37
$-54.079
$-22.991
$-8.888
$-3.33
EBIT
$-81.409
$-53.237
$-23.022
$-8.889
$-3.33
$-2.87
$-2.10
$-1.87
$-40.31
$-13.79
$-2.87
$-2.10
$-1.87
$-40.31
$-13.79